InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Tuesday, 10/25/2016 10:35:43 AM

Tuesday, October 25, 2016 10:35:43 AM

Post# of 48316
REV-1 Quote from their clients list on their website seems very confident in what Oncosec has in store for the future of cancer therapy in deep tissue indications:

Established in 2011, OncoSec Medical Inc. is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. OncoSec approached REV·1 Engineering with a need for a new Electroporation & Genetic Payload Delivery device to reach internal cancerous tumors that could not be reached with their skin-based device.
REV·1 developed multiple design solutions addressing how to access the tumors, stabilize them, and deliver OncoSec's proprietary Genetic Payload, followed by electroporating the tumors.
REV·1 designed a simple hand-held unit that can be introduced in a minimally invasive out-patient setting to access tumors deep in the body. Currently in pre-clinical trials, this device, combined with OncoSec's proprietary gene therapy, will radically change the treatment of these deep-in-the-body, life-threatening tumors.

Time will tell if Oncosec has the juice or not.....but I think they do and so does REV-1.